David Toung
Stock Analyst at Argus Research
(4.70)
# 817
Out of 5,099 analysts
351
Total ratings
65%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Hold | n/a | $44.32 | - | 12 | Nov 3, 2026 | |
| TDOC Teladoc Health | Downgraded: Sell | n/a | $8.63 | - | 6 | Nov 2, 2026 | |
| TMO Thermo Fisher Scientific | Rated: Buy | $560 → $780 | $682.65 | +14.26% | 11 | Oct 29, 2026 | |
| ABT Abbott Laboratories | Downgraded: Hold | n/a | $110.16 | - | 13 | Oct 26, 2026 | |
| TECH Bio-Techne | Downgraded: Sell | n/a | $72.67 | - | 11 | Oct 26, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Buy | $150 → $125 | $97.35 | +28.40% | 16 | Oct 21, 2026 | |
| COR Cencora | Reiterated: Buy | $400 → $380 | $337.84 | +12.48% | 20 | Oct 20, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $200 → $330 | $338.54 | -2.52% | 12 | Sep 16, 2026 | |
| ELV Elevance Health | Reiterated: Hold | n/a | $413.60 | - | 6 | Aug 20, 2026 | |
| HCA HCA Healthcare | Rated: Buy | $500 | $467.73 | +6.90% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.67 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $260 | $250.81 | +3.66% | 3 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $210 → $300 | $270.56 | +10.88% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $230 | $227.97 | +0.89% | 6 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $470 | $400.44 | +17.37% | 15 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $450 → $370 | $306.81 | +20.60% | 12 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 | $13.61 | +83.69% | 7 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310 | $355.59 | -12.82% | 3 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $258.44 | - | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $93.26 | - | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $99.29 | +15.82% | 18 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $290 → $180 | $198.60 | -9.37% | 16 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $95 | $79.55 | +19.42% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $84.75 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $410.41 | - | 21 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $570 → $775 | $998.38 | n/a | 15 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $928.29 | n/a | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 → $520 | $436.87 | n/a | 8 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $665 → $770 | $1,410.99 | n/a | 9 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $300 | $465.45 | n/a | 5 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $125 | $148.36 | n/a | 10 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 | $170.33 | n/a | 11 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $63.02 | n/a | 6 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $140 | $288.84 | n/a | 14 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $161.52 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $254.33 | n/a | 10 | Aug 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $249.01 | n/a | 1 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $4.95 | n/a | 3 | Oct 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.22 | n/a | 3 | Aug 15, 2016 |
Boston Scientific
Nov 3, 2026
Maintained: Hold
Price Target: n/a
Current: $44.32
Upside: -
Teladoc Health
Nov 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $8.63
Upside: -
Thermo Fisher Scientific
Oct 29, 2026
Rated: Buy
Price Target: $560 → $780
Current: $682.65
Upside: +14.26%
Abbott Laboratories
Oct 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $110.16
Upside: -
Bio-Techne
Oct 26, 2026
Downgraded: Sell
Price Target: n/a
Current: $72.67
Upside: -
Zimmer Biomet Holdings
Oct 21, 2026
Reiterated: Buy
Price Target: $150 → $125
Current: $97.35
Upside: +28.40%
Cencora
Oct 20, 2026
Reiterated: Buy
Price Target: $400 → $380
Current: $337.84
Upside: +12.48%
Charles River Laboratories International
Sep 16, 2026
Rated: Buy
Price Target: $200 → $330
Current: $338.54
Upside: -2.52%
Elevance Health
Aug 20, 2026
Reiterated: Hold
Price Target: n/a
Current: $413.60
Upside: -
HCA Healthcare
Aug 7, 2026
Rated: Buy
Price Target: $500
Current: $467.73
Upside: +6.90%
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.67
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $175 → $260
Current: $250.81
Upside: +3.66%
Jul 28, 2026
Rated: Buy
Price Target: $210 → $300
Current: $270.56
Upside: +10.88%
Jul 23, 2026
Rated: Buy
Price Target: $230
Current: $227.97
Upside: +0.89%
Jul 17, 2026
Reiterated: Buy
Price Target: $400 → $470
Current: $400.44
Upside: +17.37%
Jul 9, 2026
Rated: Buy
Price Target: $450 → $370
Current: $306.81
Upside: +20.60%
Jun 17, 2026
Upgraded: Buy
Price Target: $25
Current: $13.61
Upside: +83.69%
Jun 2, 2026
Reiterated: Buy
Price Target: $310
Current: $355.59
Upside: -12.82%
May 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $258.44
Upside: -
May 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $93.26
Upside: -
Apr 6, 2026
Reiterated: Buy
Price Target: $115
Current: $99.29
Upside: +15.82%
Mar 20, 2026
Rated: Buy
Price Target: $290 → $180
Current: $198.60
Upside: -9.37%
Mar 3, 2026
Rated: Buy
Price Target: $110 → $95
Current: $79.55
Upside: +19.42%
Dec 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $84.75
Upside: -
Dec 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $410.41
Upside: -
Aug 20, 2025
Rated: Buy
Price Target: $570 → $775
Current: $998.38
Upside: n/a
Aug 15, 2024
Rated: Buy
Price Target: n/a
Current: $928.29
Upside: n/a
Jul 23, 2024
Reiterated: Buy
Price Target: $450 → $520
Current: $436.87
Upside: n/a
Feb 7, 2024
Reiterated: Buy
Price Target: $665 → $770
Current: $1,410.99
Upside: n/a
Nov 6, 2023
Reiterated: Buy
Price Target: $265 → $300
Current: $465.45
Upside: n/a
Jun 6, 2023
Reiterated: Buy
Price Target: $115 → $125
Current: $148.36
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: $75
Current: $170.33
Upside: n/a
Nov 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $63.02
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $115 → $140
Current: $288.84
Upside: n/a
Mar 10, 2021
Downgraded: Hold
Price Target: n/a
Current: $161.52
Upside: n/a
Aug 27, 2019
Downgraded: Hold
Price Target: n/a
Current: $254.33
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $249.01
Upside: n/a
Oct 21, 2016
Reiterated: Buy
Price Target: $17 → $19
Current: $4.95
Upside: n/a
Aug 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $24.22
Upside: n/a